References
- Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006). Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med., 23, 469–480.
- Assuncao, N., Sudo, F. K., Drummond, C., de Felice, F. G., & Mattos, P. (2018). Metabolic syndrome and cognitive decline in the elderly: A systematic review. PLoS One, 13(3), e0194990.
- Bartos, A. & Fayette, D. (2018). Validation of the Czech Montreal Cognitive Assessment for mild cognitive impairment due to Alzheimer Disease and Czech norms in 1,552 elderly persons. Dement Geriatr Cogn Disord, 46, 335–345.
- Elliott, R. A., Goeman, D., Beanland, C., & Koch S. (2015). Ability of older people with dementia or cognitive impairment to manage medicine regimens: A narrative review. Curr Clin Pharmacol, 10(3), 213–221.
- Feinkohl, I., Janke, J., Hadzidiakos, D., et al., (2019). Associations of the metabolic syndrome and its components with cognitive impairment in older adults. BMC Geriatr, 19, 77.
- Hildrum, B., Mykletun, A., Hole, T., Midthjell, K., & Dahl, A. A. (2007). Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: The Norwegian HUNT 2 study. BMC Public Health, 7, 220.
- Leritz, E. C., McGlinchey, R. E., Kellison, I., Rudolph, J. L., & Milberg, W. P. (2011). Cardiovascular disease risk factors and cognition in the elderly. Curr Cardiovasc Risk Rep, 5(5), 407–412.
- Liu, M., He, Y., Jiang, B., et al., (2015). Association between metabolic syndrome and mild cognitive impairment and its age difference in a Chinese community elderly population. Clin Endocrinol (Oxf), 82, 844–853.
- Macekova, Z., Fazekas, T., Stanko, P., et al., Cognitive screening within advanced pharmaceutical care in elderly patients with suspected metabolic syndrome. Int J Geron. [in press]
- Maiuolo, J., Gliozzi, M., Musolino, V., et al. (2021). From metabolic syndrome to neurological diseases: Role of autophagy, Front. Cell Dev. Biol, 9, 619.
- Moonen, J. E., Sabayan, B., Sigurdsson, S., van Buchem, M. A., Gudnason, V., Meirelles, O., Launer, & L. J. (2021). Contributions of cerebral blood flow to associations between blood pressure levels and cognition: The age, gene/environment susceptibility-Reykjavik study. Hypertension, 77(6), 2,075–2,083.
- Moore, E. E. & Jefferson, A. L. (2021). Impact of cardiovascular hemodynamics on cognitive aging. Arterioscler Thromb Vasc Biol., 41(4), 1,255–1,264.
- Muller, M., Sigurdsson, S., Kjartansson, O., et al., Joint effect of mild- and late-life blood pressure on the brain: The AGES-Reykjavik study. (2014). Neurology, 82, 2,187–2,195.
- Nasreddine, Z. S., Phillips, N.A., Bédirian, V., et al. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53, 695–699.
- Oliveros, J. C. & BioinfoGP service. Venny: An interactive tool for comparing lists with Venn’s diagrams. Retrieved from https://www.bioinfogp.cnb.csic.es/tools/venny/index.html.
- Ramos, H., Pardo, J., Sánchez, R., et al. (2021). Puchades, pharmacist-physician interprofessional collaboration to promote early detection of cognitive impairment: Increasing diagnosis rate. Front Pharmacol. 12,579,489.
- Ren, L., Bai, L., Wu, Y., et al. (2018). Prevalence of and risk factors for cognitive impairment among elderly without cardio- and cerebrovascular diseases: A population-based study in rural China. Front Aging Neurosci, 10, 62.
- Ricci, G., Pirillo, I., Tomassoni, D., Sirignano, A., & Grappasonni, I. (2017). Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates. Clin. Exp. Hypertens., 39, 8–16.
- Rouch, I., Trombert, B., Kossowsky, M. P., et al. (2014). Metabolic syndrome is associated with poor memory and executive performance in elderly community residents: The PROOF study. Am J Geriatr Psychiatry, 22(11), 1,096–1,104.
- Shigaeff, N., Jacinto, A. F., Franco, F. G. M., Chiochetta, G., Cendoroglo, M. S., & Cítero, V. A. (2013). Cognitive assessment in an elderly population with metabolic syndrome in Brazil. Dement Neuropsychol, 7(2), 206–209.
- Varghese, J. F., Patel, R., & Yadav, U. C. S., (2018). Novel insights in the metabolic syndrome-induced oxidative stress and inflammation-mediated atherosclerosis. Curr. Cardiol. Rev., 14, 4–14.
- Wang, X., Howell, D., Tang, L., Shao, J., & Je, Z. (2019). Comparative study on prevalence of metabolic syndrome based on three criteria among adults in Zhejiang province, China: An observational study. BMJ Open 2020, 10, 1–8.
- Wooten, T., Ferland, T., Poole, V., et al. (2019). Metabolic risk in older adults is associated with impaired sustained attention. Neuropsychology, 33(7), 947–955.
- Yaffe, K., Middleton, L. E., Lui, L. Y., et al. (2011). Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol., 68(5), 631–636.
- Yates KF, Sweat V, Po LY, Turchiano MM, & Convit A: Impact of metabolic syndrome on cognition and brain: A selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 2012;32:2060–2067.